Research Paper
A novel cuproptosis-associated immune risk model for prediction of prognosis and response to immunotherapy in triple-negative breast cancer
Figure 5. The clinical significance of cuproptosis-related immune signature in TNBC. (A) The Kaplan-Merier curves for overall survival of low- and high-risk groups. (B) The ROC curves of CIS for predicting 1-, 3-, and 5-year overall survival in the TGCA-TNBC cohort. (C) The distribution of TNBC patients according to CIS score and survival status. (D, E) Univariate Cox analysis (D) and, multivariate Cox analysis (E) of clinical factors and CIS score in TCGA cohort. (F) Construction of nomogram for predicting 1-, 3-, and 5-year overall survival of TNBC patients. (G) Calibration curves of the nomogram for predicting the probability of OS at 1-, 3-, and 5-years survival in the TCGA cohort.